Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Nov-Dec;11(6):325-31.
doi: 10.1310/hct1106-325.

Monthly unannounced pill counts for monitoring HIV treatment adherence: tests for self-monitoring and reactivity effects

Seth C Kalichman  1 , Christina Amaral, Connie Swetsze, Lisa Eaton, Moira O Kalichman, Chauncey Cherry, Mervi Detorio, Angela M Caliendo, Raymond F Schinazi
Affiliations
Clinical Trial

Monthly unannounced pill counts for monitoring HIV treatment adherence: tests for self-monitoring and reactivity effects

Seth C Kalichman et al. HIV Clin Trials. 2010 Nov-Dec.

Abstract

Background: Unannounced home-based pill counts conducted in person or on the telephone are reliable and valid for monitoring medication adherence. However, expecting to have one's pills counted, organizing medications for pill counts, and increased attention from the person conducting the pill counts may have reactive effects and inadvertently improve adherence. The current study determined whether monthly unannounced pill counts conducted by telephone influence adherence over time.

Methods: Two prospective cohorts, one drawn from a social support condition in a behavioral intervention trial (n=186) and the other an observational study (n=187), were followed for 12 months and 8 months, respectively. Medication adherence was monitored using monthly unannounced pill counts conducted by telephone. In addition, blood plasma viral load was collected at the final pill count for the observational cohort.

Results: Analyses did not indicate increases in medication adherence over time for antiretroviral or psychiatric medications among men, women, people with detectable and undetectable viral loads, and various medication regimens.

Conclusions: Unannounced pill counts conducted by telephone do not demonstrate reactivity effects and remain a viable, unobtrusive, objective method of monitoring medication adherence.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Estimated means for adherence to antiretroviral therapy and psychiatric medications assessed by monthly unannounced pill counts, Cohort 1.
Figure 2.
Figure 2.
Estimated means for adherence to antiretroviral therapy assessed by monthly unannounced pill counts for men and women, Cohort 2.
Figure 3.
Figure 3.
Estimated means for adherence to antiretroviral therapy assessed by monthly unannounced pill counts for participants with undetectable and detectable viral load measured at 8 months, Cohort 2.
See this image and copyright information in PMC

References

    1. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301(22):2380–2382. - PubMed
    1. Bangsberg D, Kroetz DL, Deeks SG. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007;4:65–72. - PubMed
    1. Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008;197(Suppl 3):S272–278. - PubMed
    1. Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med. 2010;152(1):54–56; W–13. - PMC - PubMed
    1. Rudd P, Byyny RL, Zachary V, et al. The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther. 1989;46(2):169–176. - PubMed

Publication types

Substances